TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings. August 8, 2008
TCL Archive Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan June 14, 2013
TCL Archive ACR Presses Effort to Demonstrate Radiotherapy Is As Good As Or Better Than Surgery October 2, 1981
